COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Paul N. Newton(Mahidol University), Eurek Ranjit, Pierre Claver Kayumba, Souly Phanouvong, Michael Deats, Murray Lumpkin, Mirza Lalani, Wilbert Bannenberg, Ayenew Ashenef, Ghulam Rahim Awab, Stephen Kigera, Philip E. Coyne, Bernard D. Naughton(Trinity College Dublin), Catherine Dujardin, Nicholas Day(Mahidol University), Marya Lieberman(University of Notre Dame), Sachiko Ozawa(University of North Carolina at Chapel Hill), Facundo M. Fernández(Georgia Institute of Technology), Cassandra Kelly, Elizabeth Pisani, Tim K. Mackey(University of California San Diego), Lutz Heide(University of Tübingen), Peter Horby, Marie Antignac, Chioma Ejekam, Aleisha Brock, Marie Lamy, Jason Bower, Oksana Pyzik, Marie Gill, Lembit Rägo, Moji Christianah Adeyeye, Kazuko Kimura(Kanazawa Seiryo University), Céline Caillet(Mahidol University), Anushka Patel(UNSW Sydney), Georgina Joan Harigwo, Kim Doyle, Harparkash Kaur(London School of Hygiene & Tropical Medicine), Mohammad Sofiqur Rahman(University of California, San Francisco), Clark C. Freifeld, Kawtar Douidy, Piero Olliaro, Katherine C. Bond(Unknown), Philip Nguyen, Zaheer-Ud-Din Babar, Philippe J. Guérin(University of Oxford), Joel G. Breman, Felix Khuluza
The Lancet Global Health
April 9, 2020
Cited by 167


Related Papers